Hubei Honch Pharmaceutical

Hubei Honch Pharmaceutical is a Manufacturer/Innovator company operating in the pharmaceutical industry.

Hubei Honch Pharmaceutical Co Ltd was established in 2007 and now covers more than 25,000 square meters. We specialize in research, production and sales of anti-tumor APIs and veterinary APIs . In the field of anti-tumor drugs, we are integrating innovative drugs and generic drugs, such as Ixabepilone, Bortezomib, Vinorelbine Tartrate, etc. Some drugs have got cGMP, CEP and passed international inspection and on-site audit. In the filed of veterinary drugs, we mainly produce Melbemycine oxime, selamectin and Tulathromycin which are under the process of FDA.

Company type

Manufacturer/Innovator

Products and services

Markets

Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Address

Hubei Honch Pharmaceutical, Li shizhen Pharmaceutical Industrial Park, Hubei, Qichun County, China, 435300